immatics initiates IMA901 Phase III trial in renal cell carcinoma

		Cancer Friends Network > Types of Cancer > Adrenocortical Carcinoma
immatics initiates IMA901 Phase III trial in renal cell carcinoma

LinkBack

Thread Tools

Display Modes

#1 (permalink)

06-15-2011, 04:39 PM

cancerfr

Administrator

Join Date: Sep 2008

Posts: 47,193

immatics initiates IMA901 Phase III trial in renal cell carcinoma

igoommatics biotechnologies GmbH, a biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, announced today that the first patients have been vaccinated in the IMPRINT study, a pivotal Phase III trial with IMA901, the company's lead cancer vaccine for the treatment of renal cell carcinoma.

Tim Pearson

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Trackbacks are On Pingbacks are On Refbacks are On Forum Rules

All times are GMT. The time now is 08:54 AM.

CancerFriends.net